logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure HSR-1. Opioid substitution treatment coverage

Part (i) Opioid substitution treatment clients as a percentage of the estimated number of problem opioid users, 2011 or most recent year available

statistical graphic
 
Country   Low High Central
Latvia   3 3 3
Slovakia   5 13 10
Lithuania   14 15 15
Cyprus   16 24 20
Hungary   18 23 20
Greece   30 37 33
Croatia   32 50 42
Ireland   37 48 42
Germany   41 49 45
Malta   47 56 51
Austria   54 57 55
Czech Republic   53 59 56
The Netherlands   56 58 57
Italy   51 65 57
England   55 59 58
Luxembourg   50 76 65
Norway   54 101 70

Notes:

The graphic shows the estimated or reported number of opioid maintenance clients as a proportion of the number of problem opioid users, estimated by various methods, in each country with available data.

The symbol indicates a point estimate, a bar indicates an uncertainty interval.

Based on countries' estimates of problem opiate use (POU), estimates or estimates of problem drug use and injecting drug use, where case definitions in the country's estimates correspond to POU.

See the data on number of clients in substitution treatment in Table HSR-3 part (i) .

The problem opioid use estimates can be found in Table PDU-1 part (iii) and Figure PDU-1.

For Ireland, the 2006 problem opioid use estimate (20 790) used to calculate the coverage of opioid substitution treatment (OST) is believed to be an overestimate (Irish National Report 2011). Consequently, the OST coverage is likely to be an underestimate. In 2011 there were 8 729 clients in OST

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Standard Tables 24 (ST24) on 'treatment availability' Section 3 and Section 5, submitted by NFPs.

Reitox National Reports.

AAA BBB CCC
X 2 3 4
1 2 3 4
X 2 3 4
1 2 3 4
X 2 3 4
1 2 3 4

abcfigN

 

Page last updated: Friday, 31 May 2013